» Articles » PMID: 8413879

Spinal Cord Blood Flow and Evoked Potential Responses After Treatment with Nimodipine or Methylprednisolone in Spinal Cord-injured Rats

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 1993 Sep 1
PMID 8413879
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

This study examined the effect of nimodipine or methylprednisolone on spinal cord blood flow (SCBF) and electrophysiological function after spinal cord injury in rats. Three groups of male rats (n = 10 per group) were injured by compression of the cord at T1 for 1 minute with a 52-g clip. The hydrogen clearance technique was used to measure SCBF at the T1 segment. Motor and somatosensory evoked potentials were recorded. SCBF and evoked potentials were measured before injury and again at approximately 1 and 2.5 hours after injury. The methylprednisolone group received a bolus of methylprednisolone (30 mg/kg) at 5 minutes after injury and then at 15 minutes after injury, the group received an infusion of methylprednisolone at 5.4 mg/kg per hour. The nimodipine group received placebo at 5 minutes and then received an infusion of nimodipine at 0.02 mg/kg per hour at 15 minutes. The placebo group received placebo at both times. Physiological parameters were closely monitored and maintained within the normal range. Albumin was administered after injury to maintain mean arterial blood pressure at or above 80 mm Hg. The infusions were continued for approximately 3 hours after spinal cord injury. SCBF was not significantly different between the experimental groups at either 1 or 2.5 hours postinjury (P = 0.16 and 0.71, respectively), and evoked potential responses did not return in any rat at any time after injury. Thus, this experiment failed to demonstrate an improvement in SCBF or electrophysiological function with either drug.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Pre- and post-traumatic boric acid therapy prevents oxidative stress-mediated neuronal apoptosis in spinal cord injury.

Kandemir T, Sogut I, Ataizi Z, Can B, Oglakci-Ilhan A, Burukoglu-Donmez D Iran J Basic Med Sci. 2025; 28(4):444-450.

PMID: 39968086 PMC: 11831752. DOI: 10.22038/ijbms.2024.81531.17649.


The effects of barnidipine on an experimental ischemia reperfusion model of spinal cord injury and comparison with methyl prednisolone.

Daltaban I, Misir S, Turksoy V, Ak H, Cakir E North Clin Istanb. 2019; 6(2):103-109.

PMID: 31297474 PMC: 6593922. DOI: 10.14744/nci.2018.89411.


Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery.

Patel S, Sullivan P, Lyttle T, Magnuson D, Rabchevsky A Neuroscience. 2012; 210:296-307.

PMID: 22445934 PMC: 3358433. DOI: 10.1016/j.neuroscience.2012.03.006.


Outcome evaluation with signal activation of functional MRI in spinal cord injury.

Jung J, Oh C, Yoon S, Ha Y, Park S, Choi B J Korean Neurosurg Soc. 2011; 50(3):209-15.

PMID: 22102951 PMC: 3218180. DOI: 10.3340/jkns.2011.50.3.209.


Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics.

Mortazavi M, Verma K, Deep A, Esfahani F, Pritchard P, Tubbs R Childs Nerv Syst. 2010; 27(8):1307-16.

PMID: 21174102 DOI: 10.1007/s00381-010-1365-x.